IRON II DIN 00570370
Status: Cancelled Post Market
Holder: NUTRILITE, A DIVISION OF ACCESS BUSINESS GROUP, LLC
Molecule: FERROUS FUMARATE
Health Canada record
| Active ingredient(s) | FERROUS FUMARATE 75 MG; FERROUS GLUCONATE 26 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | B03AA30 IRON COMBINATIONS |
| Original market date | 31-Dec-1983 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FERROUS FUMARATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00265756 | FERROUS FUMARATE SCT TAB 300MG | PHARMETICS (2011) INC | Tablet | FERROUS FUMARATE 300 MG | Cancelled Post Market |
| 00415030 | FERROUS FUMARATE TAB 200MG | SHOPPERS DRUG MART INC. | Tablet | FERROUS FUMARATE 200 MG | Cancelled Post Market |
| 00718041 | IRON VITAMINS B6,B12,C,FOLIC ACID TAB | LABORATOIRE LALCO INC. | Tablet | FERROUS FUMARATE 109.4 MG; FOLIC ACID .4 MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 6 MG; VITAMIN B12 12 MCG; ASCORBIC ACID 60 MG | Cancelled Post Market |
| 00021431 | NOVO-FUMAR 200MG | NOVOPHARM LIMITED | Tablet | FERROUS FUMARATE 200 MG | Cancelled Post Market |
International API supply for FERROUS FUMARATE
2 valid EDQM Certificates of Suitability from 2 holders. 3 active FDA Drug Master Files.
Request a quote for IRON II